Montelukast Sodium
Product Images NDC 64380-258

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 64380-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph 1 (Db92eb61 1331 4f8a A5a8 329dd9354c62 01)

This text provides data on the change in height in centimeters over weeks on treatment for Montelukast 5 mg, Beclomethasone 336 mcg, and Placebo. The study included 120 participants for Montelukast, 119 for Beclomethasone, and 121 for Placebo. This information may be used for evaluating the effect of these treatments on growth in individuals.*

FDA Label Image

Structural Formula (Db92eb61 1331 4f8a A5a8 329dd9354c62 02)

FDA Label Image

Graph 2 (Db92eb61 1331 4f8a A5a8 329dd9354c62 03)

Not available.*

FDA Label Image

10 mg (Db92eb61 1331 4f8a A5a8 329dd9354c62 04)

This text provides information about a medication containing Montelukast Sodium equivalent to 10mg Montelukast. The usual dosage and storage instructions are available. It is intended for adults 16 years of age and older. The medication should be stored at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). Additional details may be found on the website www.strides.com/medication-guides.*

FDA Label Image

4mg (Db92eb61 1331 4f8a A5a8 329dd9354c62 05)

This text provides information on Montelukast Sodium Chewable Tablets, USP with a dosage of 4 mg per tablet. It gives directions for storage conditions and highlights the need to keep medications out of children's reach. It also contains a reference to the availability of a Medication Guide and NDC number for identification. Additionally, it mentions the presence of phenylalanine for pediatric patients aged 2-5 years and directs pharmacists to dispense patient information. The text mentions the manufacturer as Strides Pharma Inc. and includes their contact information.*

FDA Label Image

5mg (Db92eb61 1331 4f8a A5a8 329dd9354c62 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.